Wildy Logo
(020) 7242 5778
enquiries@wildy.com

Book of the Month

Cover of Company Directors: Duties, Liabilities and Remedies

Company Directors: Duties, Liabilities and Remedies

Edited by: Mark Arnold KC, Simon Mortimore KC
Price: £275.00

Lord Denning: Life, Law and Legacy



  


Welcome to Wildys

Watch


NEW EDITION Pre-order Mortgage Receivership: Law and Practice



 Stephanie Tozer, Cecily Crampin, Tricia Hemans
Practical guidance to relevant law & procedure


Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


Easter Closing

We will be closed between Friday 29th March and Monday 1st April for the Easter Bank Holidays, reopening at 8.30am on Tuesday 2nd April. Any orders received during this period will be processed with when we re-open.

Hide this message

This book is now Out of Print.
A new edition has been published, the details can be seen here:
Pharmaceuticals, Biotechnology and the Law 3rd ed isbn 9781405781664

Pharmaceuticals, Biotechnology and the Law 2nd ed


ISBN13: 9780406914415
New Edition ISBN: 9781405781664
Published: January 2009
Publisher: LexisNexis Butterworths
Country of Publication: UK
Format: Hardback
Price: Out of print



Wildy's Book of the Month - February 2009

Pharmaceuticals Biotechnology and the Law is the definitive guide to the law in Europe relating to pharmaceuticals, biotechnology and their related areas such as medical devices.

Written by one of the country's leading patent and regulatory lawyers, this is the only text which comprehensively covers the wide variety of legal and regulatory issues which surround these industry sectors.

The book examines the background to, and the impact of, the law affecting this area. The text is primarily written from the perspective of European Community law, although in those relatively few areas where this is not harmonised it is written from the perspective of English law.

Subjects:
Intellectual Property Law, Medical Law and Bioethics
Contents:
Introduction and Overview;
Drug discovery and industry overview;
Intellectual property overview;
Regulatory overview;
Competition law overview;
Early stage R&D;
Regulatory issues associated with early stage pharmaceuticals R&D, including ethical issues associated with stem cells, and animal experimentation;
Special regulatory issues associated with biotechnology, including contained use and deliberate release;
Patents issues associated with early stage pharmaceuticals R&D;
Patents issues associated with biotechnology;
Agreements in early stage R&D;
Late stage R&D;
Regulatory issues associated with pharmaceuticals, including clinical trials;
Regulatory issues associated with late stage R&D in other applications of biotechnology than pharmaceuticals;
Regulatory issues associated with late stage R&D in other life sciences sectors;
Patents issues associated with late stage pharmaceuticals R&D
Agreements in late stage R&D;
Trade mark issues associated with pharmaceuticals;
Post Authorisation;
Agreements for exploiting proven products, including co-marketing and co-promotion;
Regulatory issues post authorisation for pharmaceuticals, including pricing;
Regulatory issues post associated in other applications of biotechnology than pharmaceuticals;
Product liability;
Parallel Imports and Generic Competition;
Parallel imports;
Patents and generic competition;
Regulatory data protection and generic competition;